Guoxiu Du

672 total citations
6 papers, 516 citations indexed

About

Guoxiu Du is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Guoxiu Du has authored 6 papers receiving a total of 516 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 6 papers in Immunology and 1 paper in Molecular Biology. Recurrent topics in Guoxiu Du's work include CAR-T cell therapy research (6 papers), Immune Cell Function and Interaction (4 papers) and Immunotherapy and Immune Responses (4 papers). Guoxiu Du is often cited by papers focused on CAR-T cell therapy research (6 papers), Immune Cell Function and Interaction (4 papers) and Immunotherapy and Immune Responses (4 papers). Guoxiu Du collaborates with scholars based in China and United States. Guoxiu Du's co-authors include Bizhi Shi, Zonghai Li, Hua Jiang, Zhimin Shi, Hong Luo, Ruixin Sun, Honghong Zhang, Yansha Sun, Yi Wang and Qi‐Xiang Li and has published in prestigious journals such as JNCI Journal of the National Cancer Institute, Biochemical Pharmacology and Molecular Therapy.

In The Last Decade

Guoxiu Du

6 papers receiving 506 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Guoxiu Du China	6	397	233	131	84	72	6	516
Anna C. Filley United States	7	315 0.8×	225 1.0×	133 1.0×	59 0.7×	127 1.8×	10	547
Dana L. Schalk United States	13	294 0.7×	214 0.9×	170 1.3×	52 0.6×	44 0.6×	30	534
Sabine Stienen Germany	13	491 1.2×	307 1.3×	148 1.1×	69 0.8×	46 0.6×	26	639
Yansha Sun China	11	517 1.3×	295 1.3×	162 1.2×	148 1.8×	96 1.3×	20	617
Sarah C. Garrett-Thomson United States	8	497 1.3×	387 1.7×	188 1.4×	97 1.2×	30 0.4×	10	714
Kirsten L. Todd Australia	5	585 1.5×	475 2.0×	230 1.8×	118 1.4×	97 1.3×	5	800
Emma V. Petley Australia	5	624 1.6×	511 2.2×	237 1.8×	121 1.4×	101 1.4×	7	854
Catherine Flores United States	9	235 0.6×	243 1.0×	148 1.1×	50 0.6×	35 0.5×	15	426
Stina L. Wickström Sweden	14	344 0.9×	367 1.6×	145 1.1×	78 0.9×	49 0.7×	20	575

Countries citing papers authored by Guoxiu Du

Since Specialization

Citations

This map shows the geographic impact of Guoxiu Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guoxiu Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guoxiu Du more than expected).

Fields of papers citing papers by Guoxiu Du

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guoxiu Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guoxiu Du. The network helps show where Guoxiu Du may publish in the future.

Co-authorship network of co-authors of Guoxiu Du

This figure shows the co-authorship network connecting the top 25 collaborators of Guoxiu Du. A scholar is included among the top collaborators of Guoxiu Du based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guoxiu Du. Guoxiu Du is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Sun, Ruixin, Yansha Sun, Chuanlong Wu, et al.. (2023). CXCR4-modified CAR-T cells suppresses MDSCs recruitment via STAT3/NF-κB/SDF-1α axis to enhance efficacy against pancreatic cancer. Molecular Therapy. 31(11). 3193–3209. 46 indexed citations

2.

Sun, Ruixin, Min Zhou, Hong Luo, et al.. (2023). Expressing IL-15/IL-18 and CXCR2 improve infiltration and survival of EGFRvIII-targeting CAR-T cells in breast cancer. Biochemical Pharmacology. 212. 115536–115536. 14 indexed citations

3.

Wang, Yi, Honghong Zhang, Guoxiu Du, et al.. (2022). Enforced expression of Runx3 improved CAR-T cell potency in solid tumor via enhancing resistance to activation-induced cell death. Molecular Therapy. 31(3). 701–714. 21 indexed citations

4.

Sun, Ruixin, Hong Luo, Su Jingwen, et al.. (2020). Olaparib Suppresses MDSC Recruitment via SDF1α/CXCR4 Axis to Improve the Anti-tumor Efficacy of CAR-T Cells on Breast Cancer in Mice. Molecular Therapy. 29(1). 60–74. 97 indexed citations

5.

Guo, Xingliang, Hua Jiang, Bizhi Shi, et al.. (2018). Disruption of PD-1 Enhanced the Anti-tumor Activity of Chimeric Antigen Receptor T Cells Against Hepatocellular Carcinoma. Frontiers in Pharmacology. 9. 1118–1118. 159 indexed citations

6.

Jiang, Hua, Zhimin Shi, Peng Wang, et al.. (2018). Claudin18.2-Specific Chimeric Antigen Receptor Engineered T Cells for the Treatment of Gastric Cancer. JNCI Journal of the National Cancer Institute. 111(4). 409–418. 179 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact